Status:
COMPLETED
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
Lead Sponsor:
Ain Shams University
Collaborating Sponsors:
National Hepatology & Tropical Medicine Research Institute
Conditions:
Atopic
Dermatitis
Eligibility:
All Genders
2-16 years
Phase:
PHASE4
Brief Summary
Atopic dermatitis (AD) is a very common inflammatory, genetic skin disorder that occurs more frequently in children. Its exact etiology is not known but it is characterized by pruritic skin reactions ...
Detailed Description
Atopic dermatitis is a common pruritic inflammatory skin disorder. The prevalence of atopic dermatitis increased in the last three decades by two or three folds worldwide. In the developed countries, ...
Eligibility Criteria
Inclusion
- Male or female patients
- 2-16 years old
- diagnosed with Atopic Dermatitis according to Hanifin and Rajka criteria
Exclusion
- patients with serious skin disorder other than Atopic Dermatitis
- patients taking systemic corticosteroids or anti-inflammatory medications.
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05324618
Start Date
May 15 2022
End Date
April 30 2023
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute
Cairo, Egypt, 123456